Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S(+)-ketamine and perioperative proinflammatory cytokine release in radical cystectomy
PACTR201510001293646Recruiting
- Sponsor
- Cairo University
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of esketamine in bladder cancer (3 arms), sponsored by Cairo University. Primary endpoint: Release of proinflammatory cytokines. Started Oct 2015; status: recruiting.
02
Drugs
esketamine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on PACTR201510001293646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201510001293646.